Docoh
Loading...

413 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2007 Q2
EX-10.1
PRPO Precipio Inc
13 Aug 07
Quarterly report
8:00pm
. Section 3.5. Capitalization. Section 3.6. Subsidiaries. Section 3.7. Litigation. Section 3.8. Title to, Sufficiency and Condition of Assets. Section 3.9 … . Litigation. Section 5.6. Fees and Expenses of Brokers and Others. ARTICLE VI[RESERVED] ARTICLE VIICONDITIONS PRECEDENT TO THE OBLIGATIONS OF THE BUYER
8-K
EX-99.1
PRPO Precipio Inc
4 Apr 06
Departure of Directors or Principal Officers
8:00pm
of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause our actual … -looking statements contained in the Private Securities Litigation Reform Act of 1995 with respect to all statements contained in this press release
8-K
EX-99.1
PRPO Precipio Inc
5 Mar 14
Transgenomic Announces $7 Million Convertible Preferred Stock Financing
7:00pm
” of Transgenomic within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors … Litigation Reform Act of 1995 with respect to all statements contained in this press release. All information in this press release is as of the date
8-K
EX-99.1
PRPO Precipio Inc
21 Feb 06
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:00pm
of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause our actual results … for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 with respect to all statements contained
8-K
EX-99.1
PRPO Precipio Inc
5 May 14
Transgenomic Announces Uplisting to the NASDAQ Capital Market
8:00pm
statements in this press release constitute “forward-looking statements” of Transgenomic within the meaning of the Private Securities Litigation Reform Act … Securities Litigation Reform Act of 1995 with respect to all statements contained in this press release. All information in this press release
8-K
EX-99.1
5a8ws
5 Jan 12
Transgenomic Announces $3 Million Convertible Note Financing
7:00pm
8-K
EX-99
gpjwpd1g99ru jjd
28 Aug 03
Transgenomic Inc. Announces $4.5 Million Private Placement
8:00pm
8-K
EX-99.1
3y3v7s9tzhlhc0jm
4 Nov 14
TRANSGENOMIC announces executive changes
7:00pm
8-K
EX-99.1
vjq71
17 Mar 05
Entry into a Material Definitive Agreement
7:00pm
8-K
EX-99.1
d7n48
21 Oct 14
Transgenomic Announces $2.375 Million Private Placement Financing
8:00pm
8-K
etmkha9ue4dqu 3wm4c
13 Mar 16
Other Events
8:00pm
8-K
EX-99.1
l5d5djh0pdelgy5e 5kg
19 Apr 05
Other Events
8:00pm
8-K
EX-99
hh4xswrvpz6 npkyy04
30 Oct 05
Unregistered Sales of Equity Securities
7:00pm
8-K
EX-99.1
6ngg3hf
14 Nov 06
Departure of Directors or Principal Officers
7:00pm
8-K
EX-99.1
5rgoye1b9cpm
22 Sep 05
Entry into a Material Definitive Agreement
8:00pm
DEFA14A
EX-99.1
dww0u7ed
16 Apr 17
Additional proxy soliciting materials
8:00pm
8-K
EX-99.1
yf9p8lq7
10 Jan 16
Transgenomic Announces Conversion of Series a and B Preferred Securities and Extension of Loan Maturity Date
7:00pm
8-K
EX-99.1
6d2vh564fc3gw6
19 Feb 07
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:00pm
8-K
EX-99.1
kjygp xac7w
17 Apr 07
Departure of Directors or Principal Officers
8:00pm
8-K
EX-99
q5wn gksg0wzsii02qm
18 Sep 05
Other Events
8:00pm